Northamerican Energy Group Corp. (OTC: NNYG) – Wednesday’s shares stayed even at $0.018. No shares were traded. Northamerican Energy Group Corporation announced on October 24th that it executed an exclusive option with Penergy, of Midland, Texas, to purchase the leases on 1,920 acres encompassing the South Leonard (Queen/Penrose) and Rhodes (Yates/Seven Rivers) Fields in Lea County, New Mexico. These leases have 30 existing wells originally drilled by Tenneco into shallow (under 3000′) reservoirs, with just one of the existing wells currently operating out of the Yates formation; however many of the remaining 29 wells that were temporarily shut in can easily be reworked, at nominal cost, to bring them back on line with anticipated production of 5-10 Blpd of oil, and 50-100 Mcfd of natural gas. The 3-D Seismic, and geological surveys, of both these leases, and in adjacent leases east, and northeast of these leases show good promise and potential in the Devonian (9200′) and EllenBurger (11,700′) zones, as verified by initial natural gas potential of 1555 Mcfpd, 1668 Mcfpd and 4249 Mcfpd in the offsetting wells, as shown in the production reports of the east coast petroleum producer that drilled them.
Northamerican Energy Group Corp. specializes in acquiring Oil and Gas leases with proven reserves that have the potential for increased oil and natural gas production utilizing the new well production stimulation systems currently available. Northamerican’s main objective is to locate and acquire Oil and Gas Leases with upside potential for enhanced recovery and to accomplish this by employing: new and vastly improved chemical treatments for treating existing wells, acquisitions where the full potential of the lease has never been properly exploited, well workovers that utilize new equipment and technology, developmental drilling programs to drill new wells into existing proven reserves, and chemical fracture stimulation systems to improve production.
ALR Technologies, Inc. (OTCBB: ALRT)
ALR Technologies, Inc. (OTCBB: ALRT) – Wednesday’s shares stayed even at $0.10. No shares were traded. ALR Technologies, Inc. announced on October 23rd that a heart transplant patient utilizing the ALRT health management compliance reminder and monitoring system is achieving significant success with compliance to her complex medication and treatment schedule. The patient is a heart transplant patient who began the pilot in February 2006, and the first transplant patient within the Missouri Medicaid Program to use the ALRT500 system. The complexity of the individual’s regimen had been causing significant stress for the patient and her family and timing of administration is so crucial to the health of the patient. Missed medications and treatments or even lateness of administration can result in adverse affects and complications. Losing a transplanted organ has the obvious health effects with the patient as well as hundreds of thousands of dollars in additional costs to health insurance providers. The patient, Elaine, whose diagnoses include heart transplant, renal insufficiency, blood clot in her left atrium and hypertension, has four different physicians prescribe her 18 medications and 8 supplements. Elaine takes meds several times daily with a different combination of drugs each time. Additionally, she takes one medication weekly and another twice weekly. It is very important that the medications be taken timely (within 15 minutes of the correct time) as some medications are designed to work in combination with or to counteract side effects of other medications. “We are so pleased to have the use of the ALRT system,” reports Jim, Elaine’s husband. “This reminder system has made our daily activities so much easier and removes the constant worry of forgetting.”
ALR Technologies, Inc. is a pioneer in the emerging market for home health management and disease management industry. ALRT has developed technology-based, “clinically proven” medication reminder products and compliance monitoring and health intervention systems servicing the health care industry. ALRT’s products have been developed to address the growing problem of patient adherence to medical disease management treatments and activities that contribute to more than $140 billion dollars annually in excess healthcare costs. Healthcare costs in the US account for 15% of the gross domestic product and is expected to reach 25% by 2020. ALRT’s flagship product, the ALRT500 Health Management system, provides continued ongoing assistance to the patient and continued oversight after the patient has been released from the hospital, medical clinic, or the case manager has left their home.
GeneThera Inc. (OTCBB: GTHA)
GeneThera Inc. (OTCBB: GTHA) – Wednesday’s shares went up 45.00% to $0.058. 994,744 was the volume. On October 11th, GeneThera, Inc. announced the finalization, subject to final translation, of a Collaboration Agreement with Italy’s leading applied research laboratory, Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER) to collaborate on scientific research related to the diagnosis of animal transmittable diseases. The Parties to this Agreement will endeavor to validate GeneThera’s proprietary technology by comparing 10,000 samples between GeneThera’s developed test and an approved Post Mortem test under ESFA guidelines for validation. Basically, GeneThera will be responsible for supervising all aspects of the testing under this Agreement, while the Institute will provide its facilities and assist in the accreditation and validation of the tests and technology of GeneThera.
GeneThera, Inc., a development stage company, develops molecular assays for the detection of food contaminating pathogens, veterinary diseases, and genetically modified organisms primarily in the United States. In addition, it is in process of developing therapeutic vaccines for the detection of chronic wasting disease, a disease affecting elk and deer in North America; and mad cow disease. GeneThera has an agreement with Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna to collaborate on scientific research related to the diagnosis of animal transmittable diseases, such as Mad Cow Disease and Scrapie. The company, formerly known as Hand Brand Distribution, Inc., was founded by Antonio Milici. GeneThera was incorporated in 1995 and is based in Wheat Ridge, Colorado.
Dragon International Group Corporation (OTCBB: DRGG)
Dragon International Group Corporation (OTCBB: DRGG) – Wednesday’s shares closed down 3.57% to $0.135. 319,772 shares were traded. On October 16th Dragon International Group Corp. announced record operating results for the fiscal year ending June 30, 2006. The Company posted $18.43 million in net revenues, a 63% increase over fiscal year 2005 net revenues of $11.28 million. Dragon generated $1.227 million in operating income, a 620% increase compared to $175,000 in fiscal 2005. Excluding stock-based compensation and non-cash charges related to Dragon’s July 2005 debt financing and its conversion into equity this past fiscal year, EPS would have been $0.02 per share. The Company ended the fiscal year with stockholder equity of $8.246 million, approximately $0.14 per share, a record level for the Company.
Dragon International Group Corporation is one of China’s leading paper manufacturers and a distributor of a wide range of specialty paper products and packaging material. The company’s products are utilized for high end packaging in the cigarette, alcohol, gift, cosmetics, tea, and pharmaceutical industries. Dragon International has served as an agent for International Paper Company and Asia Pulp and Paper since 1998. Dragon International’s newly developed products have higher quality features than products currently available in the marketplace of China. These packaging products have the potential to immediately dominate a market currently dominated by low end packaging. Packaging products for both the consumer market of China and for exports is a focus of this company’s rapid expansion.
Who’s Your Daddy, Inc. (OTCBB: WYDY)
Who’s Your Daddy, Inc. (OTCBB: WYDY) – Wednesday’s shares decreased 8.09% to $0.795. The volume was 152,892. Who’s Your Daddy announced on October 23rd that its “King of Energy(TM)” Drink sales for the nine months ended September 30, 2006 were $1,135,000. Sales of its Regular and Sugar-Free “King of Energy” Drink commenced in the third quarter of 2005 and totaled $74,000 for the year ending 2005. In the first two quarters of 2006, sales of the two flavors grew to $156,000 and $183,000 respectively. In the third quarter of 2006, a Green Tea flavor was introduced and sales increased more than 400% to $796,000. Edon Moyal, Chief Executive Officer, commented: “We are pleased that Who’s Your Daddy recorded our third straight quarter of sales growth this year. We are committed to continue focusing on our strategic distribution plan, expanding our distribution partnerships in existing and new territories, and penetrating the energy drink market even further to increase our market share.”
Who’s Your Daddy, Inc., a California Corporation, has designed and licensed products featuring the label Who’s Your Daddy® since its inception in November, 2001. The Company holds more than a dozen trademark rights for over 300 products under the Who’s Your Daddy® label in the United States and Europe, and is currently in the process of obtaining similar trademark rights in various areas around the globe. The WYD brand expanded into the energy drink marketplace through the manufacturing and sale of the Who’s Your Daddy® “King of Energy®” drink. The Company has refocused its business plan to include the development of energy drinks within the beverage marketplace, in addition to licensing. The business strategy behind Who’s Your Daddy® focuses on maintaining the edge, energy and humor behind the Who’s Your Daddy® brand, while continuing to build brand awareness and recognition. The WYD brand is designed to be positioned within mass-market retail outlets, offering high quality, cutting edge products. The development and mass distribution of the energy drink will enable the Company to introduce other products into newly created distribution channels, allowing for economies of scale to assist in market entry and price positioning.
Nanoforce, Inc. (OTC: NNFC)
Nanoforce, Inc. (OTC: NNFC) – Wednesday’s shares increased 8.33% to $0.065. 191,617 was the volume. Nanoforce announced on October 10th the successful demonstration of STEEL SILK(tm) at the NanoTX ‘06 Conference in Dallas, Texas the week of October 2nd to 6th. The Company showcased this product at its booth and received intense interest from multiple organizations for a variety of applications. NNFC representatives answered questions about licensing and co-development opportunities for all of the materials and processes in its intellectual property portfolio. These included NNFC’s proprietary Nano-Cat(tm) petroleum catalyst line, the Poly-Web line of flocculants used to harvest micro-algae for bio-diesel, and Steel Silk, a self-assembling nano-material and one of the toughest fibers ever demonstrated worldwide. Nanoforce Director Dr. Russell R. Chianelli says, “Independent studies have shown that pound-for-pound, Steel Silk fibers exhibit about seven times the toughness of products currently used for blast protection and bullet-proof vests.”
Nanoforce is engaged in the research, development, acquisition and commercialization of advanced nanotechnology. Nanotechnology is the science of building and manipulating materials, devices and processes on the scale of atoms and molecules (one billionth of a meter). According to market research, it is estimated that worldwide revenues from products using nanotechnology will increase to $2.6 trillion in 2014, equal to about 15% of global manufacturing output, from $13 billion in 2004 (Lux Research). Nanoforce is taking advantage of rapid innovation in materials science to meet critical needs in growing industry sectors including petroleum refining and biodiesel production.
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com. NNYG Disclosure: Pentony Enterprises LLC was compensated 2,700,000 free trading shares from a non-controlling third party for profile coverage. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. ALRT Disclosure: Pentony Enterprises LLC was compensated $15,000 from a non-controlling third party for profile coverage. GTHA Disclosure: Pentony Enterprises LLC was compensated 500,000 free trading shares from a non-controlling third party for profile coverage. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. DRGG Disclosure: Pentony Enterprises LLC was compensated $22,500 from non-controlling third party ROI Group Associates for profile coverage. WYDY Disclosure: Pentony Enterprises LLC was compensated $21,000 from a non-controlling third party for profile coverage. NNFC Disclosure: Pentony Enterprises LLC was compensated $21,000 from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
